SSMXY लाइव सिग्नल्स | Getagraph.com के साथ लाभ को अधिकतम करें

Live Chart Being Loaded With Signals

Commentary (4 May 2024 @ 01:25):

Stats
आज की मात्रा	46 390.00
औसत मात्रा	79 545.00
बाजार मूल्य	10.82B
EPS	$0 ( 2024-02-08 )
अगली कमाई की तारीख	( $0 ) 2024-05-09
Last Dividend	$0.163 ( 2021-09-28 )
Next Dividend	$0 ( N/A )
P/E	37.72
ATR14	$0.0130 (0.07%)

मात्रा सहसंबंध

लंबा: -0.37 (neutral)

छोटा: -0.15 (neutral)

Signal:(55.344) Neutral

Sysmex Corporation सहसंबंध

10 सबसे अधिक सकारात्मक सहसंबंध

10 सबसे अधिक नकारात्मक सहसंबंध

क्या आप जानते हैं?

कोरलेशन एक सांख्यिकीय माप है जो दो चरों के बीच संबंध का वर्णन करता है। यह -1 से 1 तक का होता है, जहाँ -1 एक पूर्ण नकारात्मक कोरलेशन को दर्शाता है (जैसे ही एक चर बढ़ता है, दूसरा कम होता है), 1 एक पूर्ण सकारात्मक कोरलेशन को दर्शाता है (जैसे ही एक चर बढ़ता है, दूसरा भी बढ़ता है) और 0 कोई कोरलेशन नहीं होता है (चरों के बीच कोई संबंध नहीं है)।

कोरलेशन किसी भी दो चरों के बीच संबंध का विश्लेषण करने के लिए इस्तेमाल किया जा सकता है, न कि केवल स्टॉक में। यह वित्तीय, अर्थशास्त्र, मनोविज्ञान और अन्य क्षेत्रों में आमतौर पर उपयोग किया जाता है।

Sysmex Corporation सहसंबंध - मुद्रा/वस्त्र

0.79
( moderate )

0.76
( moderate )

0.00
( neutral )

0.64
( weak )

-0.75
( moderate negative )

Sysmex Corporation वित्तीय

Annual	2023
राजस्व:	$410.50B
सकल लाभ:	$216.08B (52.64 %)
EPS:	$72.94

FY	2023
राजस्व:	$410.50B
सकल लाभ:	$216.08B (52.64 %)
EPS:	$72.94

FY	2022
राजस्व:	$363.78B
सकल लाभ:	$190.59B (52.39 %)
EPS:	$70.29

FY	2021
राजस्व:	$305.07B
सकल लाभ:	$154.30B (50.58 %)
EPS:	$79.33

Financial Reports:

No articles found.

Sysmex Corporation Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)

Sysmex Corporation Dividend Information - Ex Dividend Knight

Dividend Sustainability Score: 10.00 - good (100.00%) | Divividend Growth Potential Score: 5.06 - Stable (1.26%)

Information

First Dividend	$0.162	2021-03-29
Last Dividend	$0.163	2021-09-28
Next Dividend	$0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	2	--
Total Paid Out	$0.326	--
Avg. Dividend % Per Year	0.00%	--
Score	3.79	--
Div. Sustainability Score	10.00
Div.Growth Potential Score	5.06
Div. Directional Score	9.23	--

Next Divdend (Est)
(2024-06-21)

$0 Estimate 0.00 %

Dividend Stability

0.04 Very Bad

Dividend Score

3.79

Pay Frequency

Semi-Annually

Yearly Payout

Year	Amount	Yield

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. However, its Dividend Growth Potential Score (DGPS) is only moderate, indicating limited growth potential. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.

Top 10 dividend Companies for OTC

Symbol	Title	Last dividend	Frequency	Yearly Dividend
NWYF	Ex Dividend Junior	2023-08-04	Semi-Annually	0.00%
CRRFY	Ex Dividend Junior	2023-06-06	Sporadic	0.00%
TSGTY	Ex Dividend Knight	2023-06-23	Annually	0.00%
IHICF	No Dividend Player	2023-09-28	Annually	0.00%
AUOTY	No Dividend Player	2023-08-10	Sporadic	0.00%
PTBS	Ex Dividend Knight	2023-08-03	Quarterly	0.00%
EBKDY	Ex Dividend Junior	2023-05-16	Annually	0.00%
VWAGY	Ex Dividend Junior	2023-05-11	Annually	0.00%
KIGRY	Ex Dividend Junior	2023-05-18	Annually	0.00%
BSPA	Ex Dividend Knight	2023-09-01	Quarterly	0.00%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.103	1.500	7.94	10.00	[0 - 0.5]
returnOnAssetsTTM	0.0794	1.200	7.35	8.82	[0 - 0.3]
returnOnEquityTTM	0.112	1.500	9.87	10.00	[0.1 - 1]
payoutRatioTTM	0.390	-1.000	6.10	-6.10	[0 - 1]
currentRatioTTM	3.10	0.800	10.00	8.00	[1 - 3]
quickRatioTTM	1.972	0.800	3.11	2.49	[0.8 - 2.5]
cashRatioTTM	0.603	1.500	7.76	10.00	[0.2 - 2]
debtRatioTTM	0.0579	-1.500	9.03	-10.00	[0 - 0.6]
interestCoverageTTM	38.22	1.000	10.00	10.00	[3 - 30]
operatingCashFlowPerShareTTM	108.38	2.00	10.00	10.00	[0 - 30]
freeCashFlowPerShareTTM	27.56	2.00	10.00	10.00	[0 - 20]
debtEquityRatioTTM	0.0809	-1.500	9.68	-10.00	[0 - 2.5]
grossProfitMarginTTM	0.532	1.000	4.47	4.47	[0.2 - 0.8]
operatingProfitMarginTTM	0.169	1.000	8.62	8.62	[0.1 - 0.6]
cashFlowToDebtRatioTTM	2.06	1.000	10.00	10.00	[0.2 - 2]
assetTurnoverTTM	0.773	0.800	8.18	6.55	[0.5 - 2]
Total Score				13.40

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	36.85	1.000	6.38	0	[1 - 100]
returnOnEquityTTM	0.112	2.50	9.92	10.00	[0.1 - 1.5]
freeCashFlowPerShareTTM	27.56	2.00	0.814	10.00	[0 - 30]
dividendYielPercentageTTM	0.00538	1.500	9.87	0	[0 - 0.4]
operatingCashFlowPerShareTTM	108.38	2.00	10.00	10.00	[0 - 30]
payoutRatioTTM	0.390	1.500	6.10	-6.10	[0 - 1]
pegRatioTTM	-0.0156	1.500	-3.44	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.155	1.000	8.63	0	[0.1 - 0.5]
Total Score				5.06

Sysmex Corporation

Sysmex Corporation engages in the development, manufacture, and sale of diagnostic instruments, reagents, and related software in Japan. The company offers three-part and five-part white blood cell differentiation instruments for use in hematology; and transport systems for high-volume testing in labs. It also provides urine formed sediment analysis systems; automated immunochemistry systems, which perform assays on minute sample quantities, as well as reagents to test for infectious disease and tumor markers; and flow cytometers to perform analysis in diagnosing leukemia, malignant lymphoma, and HIV/AIDS. In addition, the company offers cancer lymph node metastasis testing systems to detect information to help in diagnosing lymph node metastasis; cancer genome profiling systems; and cytogenic testing and lab assay services. It is also involved in the development and sale of software for diagnostic information systems; provision of facility management, office, and welfare services; development, manufacture, and sale of nucleic acid analogs; development, operation, and maintenance of IT solutions, platforms, and applications related to digital medicine; marketing, development, design, manufacture, sale, and after-sales service related to medical robots; and distribution and after sales support of medical devices and reagents for biotechnology, medical technology, and molecular cell analysis. The company serves national and other public hospitals, private hospitals, universities, research institutes, other medical institutions, etc. It also exports its products to approximately 190 countries. Sysmex Corporation has a strategic alliance with QIAGEN N.V. for the development and commercialization of cancer companion diagnostics using Plasma-Safe-SeqS technology. The company was formerly known as TOA Medical Electronics Co., Ltd. and changed its name to Sysmex Corporation in October 1998. Sysmex Corporation was founded in 1968 and is headquartered in Kobe, Japan.

के लिए वास्तविक समय के अद्यतन Sysmex Corporation [SSMXY]

Upcoming Earnings Alert

Sysmex Corporation Dividend Information - Ex Dividend Knight

Dividend Commentary

Top 10 dividend Companies for OTC

Dividend Sustainability Score (DSS)

Dividend Growth Score (DGS)